Sarepta Therapeutics

Senior Manager, Corporate Quality – R&D Audits

Sarepta Therapeutics$136K — $170K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • 5+ years of experience in quality audits within the pharmaceutical or biotech industry.
  • Strong knowledge of GxP regulations, including FDA, ICH, and OECD standards.
  • Experience in vendor management and audit programs.
  • Ability to analyze compliance risks effectively and propose solutions.
  • Excellent communication skills for reporting audit findings and performance oversight.

Responsibilities

  • Conduct external GPV and GLP/GCLP audits for approved vendors.
  • Develop and execute audit plans, ensuring compliance and quality standards.
  • Evaluate vendor responses against industry benchmarks to confirm quality controls.
  • Serve as the main QA contact for vendor audits and compliance decisions.
  • Assist in maintaining external audit schedules and documentation.

Benefits

  • Hybrid work environment with on-site requirements at Sarepta facilities.
  • Participation in company-sponsored in-person events.
  • Opportunity for professional growth and continuous improvement in quality systems.
Full Job Description

The Importance of the Role

The Sr. Manager, Corporate Quality Audits, provides GxP oversight for the vendor management and audit program, with primary responsibility for GPV and GLP/GCLP vendor audits. The role ensures compliance with FDA, ICH, OECD, and other global requirements, supports the integration of acquired programs, and drives continuous improvement of quality systems.

The Opportunity to Make a Difference

Primary responsibilities include:

·Conduct GPV and GLP/GCLP external audits of Sarepta approved vendors. Develop audit plans, conduct quality audits, prepare audit reports, and communicate and escalate findings, including compliance risk.

·Conduct Quality Audits associated with qualification of new vendors.

·Conduct for cause audits of external vendors as requested by management.

·Review and evaluate vendors audit response against current industry standards and guidelines to ensure sufficient controls are in place by the supplier to meet quality requirements.

·Serve as a QA point of contact for vendor-related audits, performance oversight, and compliance decision-making.

·Assist in the maintenance of the annual external audit schedules as requested by management.

·Provie support during GXP health authority inspections

·Revise and create GxP quality documentation, including SOPs, policies, templates, and work instructions.

·Manage auditing files, records, reports, licenses and certificates associated with the approved vendor program.

·Assumes additional duties and responsibilities as assigned.

More about You

Assumes additional duties and responsibilities as assigned.

What Now?

We’re always looking for solution-oriented, critical thinkers.

So, if you’re comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply.

#LI-Hybrid

#LI-ES1

This position is hybrid, you will be expected to work on site at one of Sarepta’s facilities in the United States and/or attend Company-sponsored in-person events from time to time.

The targeted salary range for this position is $136,000 - $170,000 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta’s compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity.

Candidates must be authorized to work in the U.S.

Sarepta Therapeutics offers a competitive compensation and benefit package.

About Sarepta Therapeutics

Sarepta Therapeutics, Inc. is an American biotechnology company focused on the discovery and development of RNA-targeted therapeutics. The company's lead product candidate is eteplirsen, a treatment for Duchenne muscular dystrophy (DMD). The company is also developing other RNA-targeted therapeutics for the treatment of other neuromuscular and infectious diseases. Sarepta Therapeutics was founded in 1980 as AntiVirals, Inc. and changed its name to AVI BioPharma, Inc. in 2000. The company changed its name to Sarepta Therapeutics, Inc. in 2012.
Learn more about Sarepta Therapeutics
Size
840 employees
Market Cap
$11.3 billion
Industry
Net Income
-$554.1 million
Founded
1980
5 Year Trend
+164.5%
Revenue
$540 million
NASDAQ

Similar Jobs

More Jobs at Sarepta Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Senior Manager, Corporate Quality – R&D Audits jobs: